SCIENCE IN THE NEWS DAILY
In Study, Drug Delays Worsening of Breast Cancer, With Fewer Side Effects
from the New York Times (Registration Required)
CHICAGO -- A drug that delivers a powerful poison to tumors without some of the side effects of traditional treatments can delay the worsening of breast cancer and also appears to substantially prolong lives, according to results of a study presented here [the American Society of Clinical Oncology] Saturday.
Besides representing an advance in treating breast cancer, the success in the clinical trial validates an idea that is now being pursued by numerous pharmaceutical companies to treat various types of cancer in a way that delivers drugs to cancerous cells while sparing healthy ones.
"We've envisioned a world where cancer treatment would kill the cancer and not hurt the patient," Dr. Kimberly L. Blackwell, a professor of medicine at the Duke Cancer Institute and the lead investigator in the trial, said in an interview. "And this drug does that."
Science in the Media
Magazines and Web Sites:
The Science-Media Intersection:
... for Sigma Xi SmartBrief, a free daily summary of the latest news in scientific research, delivered straight to your in-box. Each story is summarized concisely and linked directly to the original source for further reading.
Click here to subscribe.
Subscribe to Our Content!
Visit our RSS Feeds page to choose among 13 customized feeds, or create a free My AmSci account to request an email notice whenever a specified author, department or discipline appears online.